Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic
CONCLUSION: The 28-day mortality rate among patients with severe or critical COVID-19 in Hong Kong was 12.0%. Older age, history of stroke, use of renal replacement therapy, and shorter duration of lopinavir-ritonavir treatment were independent predictors of 28-day mortality.PMID:37766463 | DOI:10.12809/hkmj219876 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: A J Y Chan K C Lung J S Y Yu H P Shum T Y Tsang Source Type: research

Cluster of cases of high-dose rosuvastatin-associated rhabdomyolysis and recent reduction of rosuvastatin dose for Asians in other countries
Hong Kong Med J. 2023 Sep 28. doi: 10.12809/hkmj2310943. Online ahead of print.NO ABSTRACTPMID:37766464 | DOI:10.12809/hkmj2310943 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: M L Tse Source Type: research

Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic
CONCLUSION: The 28-day mortality rate among patients with severe or critical COVID-19 in Hong Kong was 12.0%. Older age, history of stroke, use of renal replacement therapy, and shorter duration of lopinavir-ritonavir treatment were independent predictors of 28-day mortality.PMID:37766463 | DOI:10.12809/hkmj219876 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: A J Y Chan K C Lung J S Y Yu H P Shum T Y Tsang Source Type: research

Cluster of cases of high-dose rosuvastatin-associated rhabdomyolysis and recent reduction of rosuvastatin dose for Asians in other countries
Hong Kong Med J. 2023 Sep 28. doi: 10.12809/hkmj2310943. Online ahead of print.NO ABSTRACTPMID:37766464 | DOI:10.12809/hkmj2310943 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: M L Tse Source Type: research

Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic
CONCLUSION: The 28-day mortality rate among patients with severe or critical COVID-19 in Hong Kong was 12.0%. Older age, history of stroke, use of renal replacement therapy, and shorter duration of lopinavir-ritonavir treatment were independent predictors of 28-day mortality.PMID:37766463 | DOI:10.12809/hkmj219876 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: A J Y Chan K C Lung J S Y Yu H P Shum T Y Tsang Source Type: research

Cluster of cases of high-dose rosuvastatin-associated rhabdomyolysis and recent reduction of rosuvastatin dose for Asians in other countries
Hong Kong Med J. 2023 Sep 28. doi: 10.12809/hkmj2310943. Online ahead of print.NO ABSTRACTPMID:37766464 | DOI:10.12809/hkmj2310943 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: M L Tse Source Type: research

Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic
CONCLUSION: The 28-day mortality rate among patients with severe or critical COVID-19 in Hong Kong was 12.0%. Older age, history of stroke, use of renal replacement therapy, and shorter duration of lopinavir-ritonavir treatment were independent predictors of 28-day mortality.PMID:37766463 | DOI:10.12809/hkmj219876 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: A J Y Chan K C Lung J S Y Yu H P Shum T Y Tsang Source Type: research

Cluster of cases of high-dose rosuvastatin-associated rhabdomyolysis and recent reduction of rosuvastatin dose for Asians in other countries
Hong Kong Med J. 2023 Sep 28. doi: 10.12809/hkmj2310943. Online ahead of print.NO ABSTRACTPMID:37766464 | DOI:10.12809/hkmj2310943 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: M L Tse Source Type: research

Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic
CONCLUSION: The 28-day mortality rate among patients with severe or critical COVID-19 in Hong Kong was 12.0%. Older age, history of stroke, use of renal replacement therapy, and shorter duration of lopinavir-ritonavir treatment were independent predictors of 28-day mortality.PMID:37766463 | DOI:10.12809/hkmj219876 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: A J Y Chan K C Lung J S Y Yu H P Shum T Y Tsang Source Type: research

Cluster of cases of high-dose rosuvastatin-associated rhabdomyolysis and recent reduction of rosuvastatin dose for Asians in other countries
Hong Kong Med J. 2023 Sep 28. doi: 10.12809/hkmj2310943. Online ahead of print.NO ABSTRACTPMID:37766464 | DOI:10.12809/hkmj2310943 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 28, 2023 Category: General Medicine Authors: M L Tse Source Type: research

Calcific myonecrosis misdiagnosed as right leg abscess: a case report
Hong Kong Med J. 2023 Sep 27. doi: 10.12809/hkmj219898. Online ahead of print.NO ABSTRACTPMID:37752774 | DOI:10.12809/hkmj219898 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 27, 2023 Category: General Medicine Authors: C Y Lee C H Lin Source Type: research

Indications for house dust mite allergen-specific immunotherapy
Hong Kong Med J. 2023 Sep 26. doi: 10.12809/hkmj2310696. Online ahead of print.NO ABSTRACTPMID:37749053 | DOI:10.12809/hkmj2310696 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 25, 2023 Category: General Medicine Authors: C W M Leung H C Chu J C H Leung T F Leung Source Type: research

Ultrasound-guided spinal anaesthesia in a patient with achondroplastic dwarfism and scoliosis: a case report
Hong Kong Med J. 2023 Sep 19. doi: 10.12809/hkmj2210169. Online ahead of print.NO ABSTRACTPMID:37723609 | DOI:10.12809/hkmj2210169 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - September 19, 2023 Category: General Medicine Authors: B Kilicaslan Source Type: research